News + Press Releases

PlantEXT Engages Beacon Securities Limited for $7-Million USD Brokered Private Placement

Green Eyes At the forefront of medical cannabis research, Prof. Hinanit Koltai dedicates her days to scientific research of the controversial plant • For her, every leaf, flower and seed is meaningful • As her research advances, the plant scientist believes cannabis will be used not only as a pain reliever – but as a medication in and of itself – even for cancer

Panaxia and Rafa Join with PlantEXT to Develop Cannabis Suppositories for IBD

Israeli Firms Testing Cannabis to Treat Digestive Tract Disease

Research begins to develop medical cannabis suppositories for patients suffering from IBD

Panaxia and Rafa sign a collaboration agreement with PlantEXT to research and manufacture the first medical cannabis suppositories intended for patients suffering from inflammatory bowel disease ("IBD", Crohn's and colitis)

PlantEXT Family Secret form JV to develop medical cannabis products

PlantEXT and Family Secret Execute Joint Venture Agreement to Develop, Produce and Market Topical Medical Cannabis Products

BB1 ACQUISITION CORP - PLANTEXT AND FAMILY SECRET EXECUTE JOINT VENTURE AGREEMENT TO DEVELOP, PRODUCE AND MARKET TOPICAL MEDICAL CANNABIS PRODUCTS

PlantEXT and Family Secret Execute Joint Venture Agreement to Develop, Produce and Market Topical Medical Cannabis Products